Year archive

Bright Minds Biosciences Inc. — 2024 filings

All 22 regulatory filings released by Bright Minds Biosciences Inc. (DRUG) in 2024, sourced directly from the official regulator.

22 Filings

2024 Period

2024 filings (22)

Filing	Released	Lang
Report of exempt distribution (45-106F1).pdf Regulatory Filings	2024-11-13	English
News release - English.pdf Capital/Financing Update	2024-11-04	English
News release - English.pdf Regulatory Filings	2024-10-21	English
News release - English.pdf Regulatory Filings	2024-10-16	English
News release - English.pdf Regulatory Filings	2024-10-03	English
News release - English.pdf Capital/Financing Update	2024-09-12	English
52-109F2 - Certification of interim filings - CFO (E).pdf Interim / Quarterly Report	2024-08-14	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-08-14	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-08-14	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-05-16	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-05-16	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-05-16	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-05-16	English
News release - English.pdf Declaration of Voting Results & Voting Rights Announcements	2024-03-27	English
Other.pdf Regulatory Filings	2024-02-13	English
Form of proxy - English.pdf AGM Information	2024-02-13	English
Management information circular - English.pdf AGM Information	2024-02-13	English
Notice of meeting - English.pdf AGM Information	2024-02-13	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2024-02-12	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2024-02-12	English
Interim MD&A - English.pdf Interim / Quarterly Report	2024-02-12	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2024-02-12	English